Reaction Details |
| Report a problem with these data |
Target | MAP kinase-interacting serine/threonine-protein kinase 2 |
---|
Ligand | BDBM50563891 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2085770 (CHEMBL4767033) |
---|
IC50 | 136±n/a nM |
---|
Citation | Yang, J; Chen, K; Zhang, G; Yang, QY; Li, YS; Huang, SZ; Wang, YL; Yang, W; Jiang, XJ; Yan, HX; Zhu, JQ; Xiang, R; Luo, YF; Li, WM; Wei, YQ; Li, LL; Yang, SY Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants. Eur J Med Chem143:1148-1164 (2018) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
MAP kinase-interacting serine/threonine-protein kinase 2 |
---|
Name: | MAP kinase-interacting serine/threonine-protein kinase 2 |
Synonyms: | GPRK7 | MAP kinase signal-integrating kinase 2 | MAP kinase-interacting serine/threonine-protein kinase 2 (MKNK2) | MAP kinase-interacting serine/threonine-protein kinase 2 (MnK2) | MAP-kinase interacting kinase 2 (MNK2) | MKNK2 | MKNK2_HUMAN | MNK2 |
Type: | Protein |
Mol. Mass.: | 51870.79 |
Organism: | Homo sapiens (Human) |
Description: | Q9HBH9 |
Residue: | 465 |
Sequence: | MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAK
KRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG
HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL
EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS
PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG
SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA
QVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAG
QGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA
|
|
|
BDBM50563891 |
---|
n/a |
---|
Name | BDBM50563891 |
Synonyms: | CHEMBL4793380 |
Type | Small organic molecule |
Emp. Form. | C21H25N7O3 |
Mol. Mass. | 423.4683 |
SMILES | CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4NCCCOc34)cc2)no1 |
Structure |
|